data_1rto_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rto _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.544 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 35.8 Cg_endo -77.92 -89.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.652 2.234 . . . . 0.0 110.443 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 2' ' ' PRO . 55.5 m-85 -161.54 63.52 0.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.305 -0.872 . . . . 0.0 109.471 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.423 ' O ' ' HB1' ' B' ' 13' ' ' ALA . 49.4 m -87.29 59.55 5.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.502 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.3 p -89.95 52.42 2.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.396 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.406 ' C ' ' SG ' ' B' ' 50' ' ' CYS . 29.7 m-20 -138.8 164.63 29.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.875 . . . . 0.0 109.491 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.51 ' CG2' ' SG ' ' B' ' 11' ' ' CYS . 76.3 p -72.08 159.99 33.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.432 ' O ' ' O ' ' B' ' 8' ' ' THR . 22.9 m -113.83 132.34 22.67 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 109.274 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.474 ' O ' ' CG2' ' A' ' 30' ' ' THR . 35.4 Cg_endo -78.3 90.91 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.409 2.073 . . . . 0.0 110.271 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.525 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 95.7 m -105.52 116.89 32.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.622 -179.833 -66.036 -71.452 -55.896 104.091 2.019 104.105 -71.354 -42.144 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.513 ' SG ' ' CG2' ' B' ' 7' ' ' THR . 1.2 m -103.25 129.15 50.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.879 . . . . 0.0 109.447 179.84 -97.793 -88.605 -57.137 104.135 2.02 104.158 -69.349 -49.875 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.609 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -118.4 -19.01 9.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.573 ' O ' ' CD1' ' A' ' 14' ' ' TYR . . . -90.1 164.51 14.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.513 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.573 ' CD1' ' O ' ' A' ' 13' ' ' ALA . 23.1 m-85 -139.1 103.72 4.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.893 . . . . 0.0 109.437 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.44 ' CG2' ' O ' ' A' ' 15' ' ' ILE . 6.4 tt -60.07 124.82 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.455 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.31 -36.55 71.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.452 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -81.34 148.18 62.3 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.477 ' HB3' ' CG ' ' A' ' 57' ' ' TRP . 35.6 Cg_endo -78.1 170.25 19.04 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.614 2.209 . . . . 0.0 110.511 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.584 HD13 ' CZ3' ' A' ' 57' ' ' TRP . 0.0 OUTLIER -109.74 170.59 5.2 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.297 -0.877 . . . . 0.0 109.294 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.453 ' O ' HG13 ' A' ' 24' ' ' ILE . 35.9 Cg_endo -78.74 120.24 4.66 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.587 2.191 . . . . 0.0 110.18 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.41 ' CG ' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -68.63 -7.97 37.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.63 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.23 -0.13 57.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 109.8 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.451 ' HB2' ' HG2' ' A' ' 20' ' ' PRO . 14.3 m-70 -132.4 10.38 4.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.095 -1.003 . . . . 0.0 109.772 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 24' ' ' ILE . 9.6 mt -91.96 87.74 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.56 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -56.15 -65.13 0.65 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 109.544 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -157.55 152.09 25.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.487 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 29.1 p90 -123.25 -178.26 3.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.558 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.577 ' CE1' ' HB ' ' A' ' 40' ' ' VAL . 8.6 p90 -171.13 157.44 5.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 109.325 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.642 ' CE2' ' CG2' ' A' ' 39' ' ' VAL . 85.9 m-85 -89.82 165.09 14.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 0.0 109.583 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 9' ' ' PRO . 16.9 p -147.53 143.37 27.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.404 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 37' ' ' PRO . 4.6 t -179.04 -159.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 109.536 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.94 -80.55 1.08 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.578 ' HD2' ' CE1' ' B' ' 12' ' ' PHE . 21.2 mttt -89.79 30.29 1.07 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 109.363 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 m -128.54 156.36 43.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.487 -179.883 -42.144 -71.354 -55.896 104.105 2.019 104.091 -71.452 -66.036 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.08 -35.41 78.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.463 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.01 149.69 28.1 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 0.0 109.389 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.464 ' HB3' ' OG ' ' A' ' 31' ' ' SER . 35.6 Cg_endo -78.1 131.75 11.12 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.617 2.211 . . . . 0.0 110.231 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.71 173.67 13.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 109.553 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.642 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 37.3 t -95.62 166.29 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.425 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.577 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 41.0 t -140.37 112.59 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.284 -0.885 . . . . 0.0 109.309 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -93.29 112.72 24.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.556 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.567 HG22 ' CE2' ' A' ' 28' ' ' PHE . 61.3 t -100.51 126.84 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.474 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 47' ' ' ARG . 61.8 p -89.76 -169.64 2.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 0.0 109.545 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -77.8 -16.59 58.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.91 29.2 1.22 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.477 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.29 26.7 4.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.442 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 8.1 mmm180 -90.02 114.14 25.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.445 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -90.77 126.97 36.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.49 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 50' ' ' CYS . 54.7 t -118.58 160.27 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 109.428 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.455 ' N ' HG13 ' A' ' 49' ' ' VAL . 30.2 m -108.52 130.82 55.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 109.553 -179.958 -49.875 -69.349 -57.137 104.158 2.02 104.135 -88.605 -97.793 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 39' ' ' VAL . . . -136.74 134.93 37.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.373 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.419 ' CG ' ' HD2' ' A' ' 53' ' ' PRO . 10.6 t30 -89.91 145.56 33.46 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.355 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HD2' ' CG ' ' A' ' 52' ' ' ASN . 35.5 Cg_endo -78.01 5.09 5.6 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.598 2.199 . . . . 0.0 110.488 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -98.23 11.17 38.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 109.405 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 15.1 mmtt -93.52 -178.14 4.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.523 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' A' ' 57' ' ' TRP . 2.9 ptpt -103.72 -23.46 13.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.474 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.584 ' CZ3' HD13 ' A' ' 19' ' ' LEU . 46.7 p-90 -102.08 -22.34 14.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 0.0 109.534 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.516 ' CG2' ' HB2' ' A' ' 55' ' ' LYS . 83.7 t -63.46 -60.39 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.152 -0.967 . . . . 0.0 108.893 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.444 ' HA ' HD11 ' A' ' 62' ' ' ILE . 2.3 ttp180 -59.1 -16.98 22.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.343 -0.848 . . . . 0.0 108.767 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 57' ' ' TRP . 5.0 mt-10 -68.36 -44.68 74.69 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.442 -0.786 . . . . 0.0 109.138 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.471 ' OH ' ' O ' ' A' ' 19' ' ' LEU . 14.0 m-85 -71.36 -41.26 69.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.0 109.035 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.444 HD11 ' HA ' ' A' ' 59' ' ' ARG . 2.0 mp -62.25 -31.98 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 109.5 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -81.62 -31.02 32.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.51 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.0 p -79.27 -18.14 53.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 109.463 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -46.24 8.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 67' ' ' MET . 3.4 mt-10 -88.9 52.41 2.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.456 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -53.74 -171.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.441 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.45 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.546 ' O ' ' CG ' ' B' ' 3' ' ' TYR . 35.4 Cg_endo -77.93 -89.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.664 2.243 . . . . 0.0 110.415 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' B' ' 2' ' ' PRO . 55.5 m-85 -161.49 63.48 0.26 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.502 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.413 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 49.2 m -87.35 59.57 5.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.427 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 8.3 p -89.97 52.44 2.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.408 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . 0.4 ' C ' ' SG ' ' A' ' 50' ' ' CYS . 29.9 m-20 -138.79 164.66 29.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.472 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.513 ' CG2' ' SG ' ' A' ' 11' ' ' CYS . 76.5 p -72.09 159.99 33.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.895 . . . . 0.0 109.485 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 8' ' ' THR . 22.9 m -113.82 132.35 22.66 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 109.281 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' PRO . . . . . 0.482 ' O ' ' CG2' ' B' ' 30' ' ' THR . 35.3 Cg_endo -78.28 90.94 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.426 2.084 . . . . 0.0 110.251 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' CYS . . . . . 0.516 ' O ' ' CE1' ' B' ' 12' ' ' PHE . 95.3 m -105.6 116.91 32.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.6 -179.844 -66.081 -71.398 -55.94 104.102 2.019 104.087 -71.359 -42.13 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.51 ' SG ' ' CG2' ' A' ' 7' ' ' THR . 1.2 m -103.22 129.19 50.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.389 179.88 -97.853 -88.585 -57.073 104.18 2.021 104.127 -69.392 -49.833 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' B' ' 12' ' ' PHE . 0.2 OUTLIER -118.51 -18.91 8.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 109.425 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.575 ' O ' ' CD1' ' B' ' 14' ' ' TYR . . . -90.13 164.53 14.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.493 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . 0.575 ' CD1' ' O ' ' B' ' 13' ' ' ALA . 23.1 m-85 -139.15 103.73 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' B' ' 15' ' ' ILE . 6.5 tt -60.05 124.79 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.902 . . . . 0.0 109.518 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.29 -36.58 71.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.92 . . . . 0.0 109.443 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -81.31 148.23 62.56 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.494 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . 0.478 ' HB3' ' CG ' ' B' ' 57' ' ' TRP . 35.6 Cg_endo -78.15 170.25 19.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.607 2.204 . . . . 0.0 110.495 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.572 HD13 ' CZ3' ' B' ' 57' ' ' TRP . 0.0 OUTLIER -109.72 170.61 5.18 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 0.0 109.278 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.461 ' O ' HG13 ' B' ' 24' ' ' ILE . 35.5 Cg_endo -78.76 120.23 4.65 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.552 2.168 . . . . 0.0 110.156 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.403 ' CG ' ' CE1' ' B' ' 61' ' ' TYR . 0.0 OUTLIER -68.59 -8.02 38.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 109.594 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.21 -0.18 57.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.789 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.456 ' HB2' ' HG2' ' B' ' 20' ' ' PRO . 14.3 m-70 -132.36 10.33 4.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.098 -1.001 . . . . 0.0 109.754 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.461 HG13 ' O ' ' B' ' 20' ' ' PRO . 9.6 mt -91.92 87.73 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -56.17 -65.17 0.65 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.552 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -157.5 152.14 25.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' B' ' 40' ' ' VAL . 29.0 p90 -123.34 -178.31 3.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 109.571 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.577 ' CE1' ' HB ' ' B' ' 40' ' ' VAL . 8.6 p90 -171.1 157.5 5.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.319 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' B' ' 39' ' ' VAL . 85.9 m-85 -89.84 165.09 14.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.574 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.482 ' CG2' ' O ' ' B' ' 9' ' ' PRO . 16.9 p -147.54 143.42 27.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.382 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' B' ' 37' ' ' PRO . 4.6 t -179.09 -159.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 109.535 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.98 -80.55 1.08 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.583 ' HD2' ' CE1' ' A' ' 12' ' ' PHE . 21.3 mttt -89.85 30.31 1.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -1.129 . . . . 0.0 109.369 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 m -128.51 156.36 43.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.264 -0.897 . . . . 0.0 109.536 -179.893 -42.13 -71.359 -55.94 104.087 2.019 104.102 -71.398 -66.081 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -35.46 78.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.01 149.67 28.04 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 109.341 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.449 ' HB3' ' OG ' ' B' ' 31' ' ' SER . 35.9 Cg_endo -78.06 131.79 11.17 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.597 2.198 . . . . 0.0 110.277 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.69 173.67 13.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.937 . . . . 0.0 109.586 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.635 ' CG2' ' CE2' ' B' ' 29' ' ' TYR . 37.3 t -95.6 166.34 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.415 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.577 ' HB ' ' CE1' ' B' ' 28' ' ' PHE . 41.1 t -140.45 112.63 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.877 . . . . 0.0 109.322 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -93.32 112.75 24.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.536 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.567 HG22 ' CE2' ' B' ' 28' ' ' PHE . 61.2 t -100.51 126.8 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.454 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.455 ' OG1' ' HB2' ' B' ' 47' ' ' ARG . 62.0 p -89.75 -169.63 2.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -0.853 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -77.8 -16.51 58.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.508 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.96 29.18 1.23 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.27 26.69 4.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.399 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ARG . . . . . 0.455 ' HB2' ' OG1' ' B' ' 43' ' ' THR . 8.1 mmm180 -90.01 114.16 25.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.473 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -90.75 127.01 36.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.487 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 54.6 t -118.6 160.23 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' CYS . . . . . 0.458 ' N ' HG13 ' B' ' 49' ' ' VAL . 30.0 m -108.47 130.84 55.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 -179.939 -49.833 -69.392 -57.073 104.127 2.021 104.18 -88.585 -97.853 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' B' ' 39' ' ' VAL . . . -136.81 134.94 37.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.875 . . . . 0.0 109.347 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . 0.417 ' OD1' ' HD2' ' B' ' 53' ' ' PRO . 10.6 t30 -89.89 145.53 33.44 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 109.363 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . 0.417 ' HD2' ' OD1' ' B' ' 52' ' ' ASN . 35.3 Cg_endo -78.05 5.13 5.59 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.587 2.191 . . . . 0.0 110.485 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -98.29 11.27 38.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.405 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . 0.52 ' HB2' ' CG2' ' B' ' 58' ' ' VAL . 15.1 mmtt -93.56 -178.12 4.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.917 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.471 ' HG3' ' N ' ' B' ' 57' ' ' TRP . 2.9 ptpt -103.75 -23.45 13.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.418 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' TRP . . . . . 0.572 ' CZ3' HD13 ' B' ' 19' ' ' LEU . 46.4 p-90 -102.05 -22.42 14.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.457 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' B' ' 55' ' ' LYS . 83.8 t -63.41 -60.35 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.136 -0.977 . . . . 0.0 108.889 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ARG . . . . . 0.457 ' HA ' HD11 ' B' ' 62' ' ' ILE . 2.3 ttp180 -59.15 -16.96 22.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.295 -0.878 . . . . 0.0 108.698 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' B' ' 57' ' ' TRP . 5.0 mt-10 -68.42 -44.74 74.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.415 -0.803 . . . . 0.0 109.053 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.469 ' OH ' ' O ' ' B' ' 19' ' ' LEU . 14.0 m-85 -71.28 -41.25 70.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.307 -0.871 . . . . 0.0 109.063 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.457 HD11 ' HA ' ' B' ' 59' ' ' ARG . 2.0 mp -62.31 -31.98 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -81.64 -30.92 32.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.546 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 56.3 p -79.33 -18.14 53.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 109.447 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.13 -46.28 8.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 109.46 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' B' ' 67' ' ' MET . 3.4 mt-10 -88.88 52.44 2.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.18 -0.95 . . . . 0.0 109.482 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' MET . . . . . 0.46 ' O ' ' O ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -53.73 -171.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.455 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.483 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.544 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 35.8 Cg_endo -77.92 -89.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.652 2.234 . . . . 0.0 110.443 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 2' ' ' PRO . 55.5 m-85 -161.54 63.52 0.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.305 -0.872 . . . . 0.0 109.471 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.4 m -87.29 59.55 5.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.633 ' HA ' ' HB3' ' B' ' 13' ' ' ALA . 8.3 p -89.95 52.42 2.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.396 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.406 ' C ' ' SG ' ' B' ' 50' ' ' CYS . 29.7 m-20 -138.8 164.63 29.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.875 . . . . 0.0 109.491 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.716 HG22 ' SG ' ' B' ' 11' ' ' CYS . 76.3 p -72.08 159.99 33.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.432 ' O ' ' O ' ' B' ' 8' ' ' THR . 22.9 m -113.83 132.34 22.67 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 109.274 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.544 ' O ' HG21 ' A' ' 30' ' ' THR . 35.4 Cg_endo -78.3 90.91 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.409 2.073 . . . . 0.0 110.271 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.525 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 95.7 m -105.52 116.89 32.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.622 -179.833 -66.036 -71.452 -55.896 104.091 2.019 104.105 -71.354 -42.144 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.707 ' SG ' HG22 ' B' ' 7' ' ' THR . 1.2 m -103.25 129.15 50.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.879 . . . . 0.0 109.447 179.84 -97.793 -88.605 -57.137 104.135 2.02 104.158 -69.349 -49.875 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.609 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -118.4 -19.01 9.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.634 ' HB3' ' HA ' ' B' ' 5' ' ' SER . . . -90.1 164.51 14.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.513 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.573 ' CD1' ' O ' ' A' ' 13' ' ' ALA . 23.1 m-85 -139.1 103.72 4.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.893 . . . . 0.0 109.437 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 15' ' ' ILE . 6.4 tt -60.07 124.82 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.455 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.31 -36.55 71.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.452 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 6.2 mtt180 -81.34 148.18 62.3 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.487 ' HB3' ' CG ' ' A' ' 57' ' ' TRP . 35.6 Cg_endo -78.1 170.25 19.04 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.614 2.209 . . . . 0.0 110.511 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.537 HD11 ' CZ3' ' A' ' 57' ' ' TRP . 0.0 OUTLIER -109.74 170.59 5.2 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.297 -0.877 . . . . 0.0 109.294 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 19' ' ' LEU . 35.9 Cg_endo -78.74 120.24 4.66 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.587 2.191 . . . . 0.0 110.18 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.41 ' CG ' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -68.63 -7.97 37.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.63 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.23 -0.13 57.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 109.8 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.469 ' HB2' ' HG2' ' A' ' 20' ' ' PRO . 13.3 m80 -132.4 10.38 4.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.095 -1.003 . . . . 0.0 109.772 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 20' ' ' PRO . 9.6 mt -91.96 87.74 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.56 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -56.15 -65.13 0.65 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 109.544 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -157.55 152.09 25.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.487 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.931 ' OH ' HG23 ' A' ' 62' ' ' ILE . 29.1 p90 -123.25 -178.26 3.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.558 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.692 ' CZ ' HG11 ' A' ' 40' ' ' VAL . 8.6 p90 -171.13 157.44 5.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 109.325 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.727 ' CE2' HG22 ' A' ' 39' ' ' VAL . 85.9 m-85 -89.82 165.09 14.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 0.0 109.583 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.544 HG21 ' O ' ' A' ' 9' ' ' PRO . 16.9 p -147.53 143.37 27.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.404 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.452 ' OG ' ' HB3' ' A' ' 37' ' ' PRO . 4.6 t -179.04 -159.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 109.536 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.94 -80.55 1.08 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.593 ' HD2' ' CE1' ' B' ' 12' ' ' PHE . 21.2 mttt -89.79 30.29 1.07 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 109.363 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 m -128.54 156.36 43.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.487 -179.883 -42.144 -71.354 -55.896 104.105 2.019 104.091 -71.452 -66.036 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.08 -35.41 78.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.463 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.01 149.69 28.1 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 0.0 109.389 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.452 ' HB3' ' OG ' ' A' ' 31' ' ' SER . 35.6 Cg_endo -78.1 131.75 11.12 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.617 2.211 . . . . 0.0 110.231 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.438 ' HB1' ' HE1' ' A' ' 14' ' ' TYR . . . -149.71 173.67 13.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 109.553 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.727 HG22 ' CE2' ' A' ' 29' ' ' TYR . 37.3 t -95.62 166.29 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.425 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.692 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 41.0 t -140.37 112.59 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.284 -0.885 . . . . 0.0 109.309 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -93.29 112.72 24.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.556 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.668 HG21 ' HE2' ' A' ' 28' ' ' PHE . 61.3 t -100.51 126.84 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.474 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 47' ' ' ARG . 61.8 p -89.76 -169.64 2.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 0.0 109.545 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -77.8 -16.59 58.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.91 29.2 1.22 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.477 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.29 26.7 4.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 8.1 mmm180 -90.02 114.14 25.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.445 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.654 ' HG3' HG22 ' A' ' 42' ' ' VAL . 6.3 mp0 -90.77 126.97 36.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.49 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 50' ' ' CYS . 54.7 t -118.58 160.27 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 109.428 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.487 ' N ' HG12 ' A' ' 49' ' ' VAL . 30.2 m -108.52 130.82 55.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 109.553 -179.958 -49.875 -69.349 -57.137 104.158 2.02 104.135 -88.605 -97.793 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 39' ' ' VAL . . . -136.74 134.93 37.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.373 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.522 ' O ' HG11 ' A' ' 58' ' ' VAL . 10.6 t30 -89.91 145.56 33.46 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.355 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HD2' ' OD1' ' A' ' 52' ' ' ASN . 35.5 Cg_endo -78.01 5.09 5.6 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.598 2.199 . . . . 0.0 110.488 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -98.23 11.17 38.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 109.405 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.534 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 15.1 mmtt -93.52 -178.14 4.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.523 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 57' ' ' TRP . 2.9 ptpt -103.72 -23.46 13.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.474 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.619 ' CH2' HG22 ' A' ' 58' ' ' VAL . 46.7 p-90 -102.08 -22.34 14.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 0.0 109.534 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.74 ' O ' HD12 ' A' ' 62' ' ' ILE . 83.7 t -63.46 -60.39 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.152 -0.967 . . . . 0.0 108.893 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -59.1 -16.98 22.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.343 -0.848 . . . . 0.0 108.767 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 57' ' ' TRP . 5.0 mt-10 -68.36 -44.68 74.69 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.442 -0.786 . . . . 0.0 109.138 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.483 ' CE2' HD12 ' A' ' 19' ' ' LEU . 14.0 m-85 -71.36 -41.26 69.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.0 109.035 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.931 HG23 ' OH ' ' A' ' 27' ' ' TYR . 2.0 mp -62.25 -31.98 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 109.5 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -81.62 -31.02 32.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.51 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.0 p -79.27 -18.14 53.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 109.463 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -46.24 8.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 67' ' ' MET . 3.4 mt-10 -88.9 52.41 2.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.456 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -53.74 -171.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.441 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.45 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.546 ' O ' ' CG ' ' B' ' 3' ' ' TYR . 35.4 Cg_endo -77.93 -89.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.664 2.243 . . . . 0.0 110.415 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' B' ' 2' ' ' PRO . 55.5 m-85 -161.49 63.48 0.26 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.502 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 49.2 m -87.35 59.57 5.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.427 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.634 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 8.3 p -89.97 52.44 2.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.408 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ASP . . . . . 0.4 ' C ' ' SG ' ' A' ' 50' ' ' CYS . 29.9 m-20 -138.79 164.66 29.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.472 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.707 HG22 ' SG ' ' A' ' 11' ' ' CYS . 76.5 p -72.09 159.99 33.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.895 . . . . 0.0 109.485 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 8' ' ' THR . 22.9 m -113.82 132.35 22.66 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 109.281 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' PRO . . . . . 0.542 ' O ' HG21 ' B' ' 30' ' ' THR . 35.3 Cg_endo -78.28 90.94 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.426 2.084 . . . . 0.0 110.251 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' CYS . . . . . 0.516 ' O ' ' CE1' ' B' ' 12' ' ' PHE . 95.3 m -105.6 116.91 32.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.6 -179.844 -66.081 -71.398 -55.94 104.102 2.019 104.087 -71.359 -42.13 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.716 ' SG ' HG22 ' A' ' 7' ' ' THR . 1.2 m -103.22 129.19 50.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.389 179.88 -97.853 -88.585 -57.073 104.18 2.021 104.127 -69.392 -49.833 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' B' ' 12' ' ' PHE . 0.2 OUTLIER -118.51 -18.91 8.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 109.425 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.633 ' HB3' ' HA ' ' A' ' 5' ' ' SER . . . -90.13 164.53 14.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.493 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' TYR . . . . . 0.575 ' CD1' ' O ' ' B' ' 13' ' ' ALA . 23.1 m-85 -139.15 103.73 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ILE . . . . . 0.562 ' O ' HG23 ' B' ' 15' ' ' ILE . 6.5 tt -60.05 124.79 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.902 . . . . 0.0 109.518 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.29 -36.58 71.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.92 . . . . 0.0 109.443 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -81.31 148.23 62.56 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.494 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' PRO . . . . . 0.49 ' HB3' ' CG ' ' B' ' 57' ' ' TRP . 35.6 Cg_endo -78.15 170.25 19.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.607 2.204 . . . . 0.0 110.495 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.543 HD11 ' CZ3' ' B' ' 57' ' ' TRP . 0.0 OUTLIER -109.72 170.61 5.18 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 0.0 109.278 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' B' ' 19' ' ' LEU . 35.5 Cg_endo -78.76 120.23 4.65 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.552 2.168 . . . . 0.0 110.156 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.403 ' CG ' ' CE1' ' B' ' 61' ' ' TYR . 0.0 OUTLIER -68.59 -8.02 38.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 109.594 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.21 -0.18 57.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.789 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.469 ' HB2' ' HG2' ' B' ' 20' ' ' PRO . 13.4 m80 -132.36 10.33 4.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.098 -1.001 . . . . 0.0 109.754 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.469 HG13 ' O ' ' B' ' 20' ' ' PRO . 9.6 mt -91.92 87.73 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -56.17 -65.17 0.65 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.552 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -157.5 152.14 25.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.921 ' OH ' HG23 ' B' ' 62' ' ' ILE . 29.0 p90 -123.34 -178.31 3.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 109.571 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.702 ' CZ ' HG11 ' B' ' 40' ' ' VAL . 8.6 p90 -171.1 157.5 5.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.319 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.724 ' CE2' HG22 ' B' ' 39' ' ' VAL . 85.9 m-85 -89.84 165.09 14.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.574 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.542 HG21 ' O ' ' B' ' 9' ' ' PRO . 16.9 p -147.54 143.42 27.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.382 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.434 ' OG ' ' HB3' ' B' ' 37' ' ' PRO . 4.6 t -179.09 -159.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 109.535 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.98 -80.55 1.08 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.597 ' HD2' ' CE1' ' A' ' 12' ' ' PHE . 21.3 mttt -89.85 30.31 1.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -1.129 . . . . 0.0 109.369 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 m -128.51 156.36 43.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.264 -0.897 . . . . 0.0 109.536 -179.893 -42.13 -71.359 -55.94 104.087 2.019 104.102 -71.398 -66.081 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -35.46 78.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.01 149.67 28.04 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 109.341 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.434 ' HB3' ' OG ' ' B' ' 31' ' ' SER . 35.9 Cg_endo -78.06 131.79 11.17 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.597 2.198 . . . . 0.0 110.277 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.445 ' HB1' ' HE1' ' B' ' 14' ' ' TYR . . . -149.69 173.67 13.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.937 . . . . 0.0 109.586 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.724 HG22 ' CE2' ' B' ' 29' ' ' TYR . 37.3 t -95.6 166.34 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.415 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.702 HG11 ' CZ ' ' B' ' 28' ' ' PHE . 41.1 t -140.45 112.63 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.877 . . . . 0.0 109.322 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -93.32 112.75 24.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.536 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.668 HG22 ' HG3' ' B' ' 48' ' ' GLN . 61.2 t -100.51 126.8 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.454 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.46 ' OG1' ' HB2' ' B' ' 47' ' ' ARG . 62.0 p -89.75 -169.63 2.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -0.853 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -77.8 -16.51 58.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.508 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.96 29.18 1.23 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.27 26.69 4.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.399 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ARG . . . . . 0.46 ' HB2' ' OG1' ' B' ' 43' ' ' THR . 8.1 mmm180 -90.01 114.16 25.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.473 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLN . . . . . 0.668 ' HG3' HG22 ' B' ' 42' ' ' VAL . 6.3 mp0 -90.75 127.01 36.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.487 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.49 HG12 ' N ' ' B' ' 50' ' ' CYS . 54.6 t -118.6 160.23 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' CYS . . . . . 0.49 ' N ' HG12 ' B' ' 49' ' ' VAL . 30.0 m -108.47 130.84 55.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 -179.939 -49.833 -69.392 -57.073 104.127 2.021 104.18 -88.585 -97.853 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' B' ' 39' ' ' VAL . . . -136.81 134.94 37.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.875 . . . . 0.0 109.347 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ASN . . . . . 0.531 ' O ' HG11 ' B' ' 58' ' ' VAL . 10.6 t30 -89.89 145.53 33.44 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 109.363 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' PRO . . . . . 0.448 ' HD2' ' OD1' ' B' ' 52' ' ' ASN . 35.3 Cg_endo -78.05 5.13 5.59 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.587 2.191 . . . . 0.0 110.485 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -98.29 11.27 38.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.405 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.535 ' HB2' ' CG2' ' B' ' 58' ' ' VAL . 15.1 mmtt -93.56 -178.12 4.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.917 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' B' ' 57' ' ' TRP . 2.9 ptpt -103.75 -23.45 13.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.418 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' TRP . . . . . 0.618 ' CH2' HG22 ' B' ' 58' ' ' VAL . 46.4 p-90 -102.05 -22.42 14.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.457 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.744 ' O ' HD12 ' B' ' 62' ' ' ILE . 83.8 t -63.41 -60.35 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.136 -0.977 . . . . 0.0 108.889 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -59.15 -16.96 22.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.295 -0.878 . . . . 0.0 108.698 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' B' ' 57' ' ' TRP . 5.0 mt-10 -68.42 -44.74 74.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.415 -0.803 . . . . 0.0 109.053 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.496 ' HE2' HD12 ' B' ' 19' ' ' LEU . 14.0 m-85 -71.28 -41.25 70.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.307 -0.871 . . . . 0.0 109.063 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.921 HG23 ' OH ' ' B' ' 27' ' ' TYR . 2.0 mp -62.31 -31.98 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -81.64 -30.92 32.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.546 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 56.3 p -79.33 -18.14 53.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 109.447 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.13 -46.28 8.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 109.46 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' B' ' 67' ' ' MET . 3.4 mt-10 -88.88 52.44 2.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.18 -0.95 . . . . 0.0 109.482 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' MET . . . . . 0.46 ' O ' ' O ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -53.73 -171.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.455 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.483 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.544 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 35.8 Cg_endo -77.92 -89.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.652 2.234 . . . . 0.0 110.443 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 2' ' ' PRO . 55.5 m-85 -161.54 63.52 0.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.305 -0.872 . . . . 0.0 109.471 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.4 m -87.29 59.55 5.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.633 ' HA ' ' HB3' ' B' ' 13' ' ' ALA . 8.3 p -89.95 52.42 2.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.396 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.406 ' C ' ' SG ' ' B' ' 50' ' ' CYS . 29.7 m-20 -138.8 164.63 29.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.875 . . . . 0.0 109.491 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.716 HG22 ' SG ' ' B' ' 11' ' ' CYS . 76.3 p -72.08 159.99 33.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.432 ' O ' ' O ' ' B' ' 8' ' ' THR . 22.9 m -113.83 132.34 22.67 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 109.274 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.544 ' O ' HG21 ' A' ' 30' ' ' THR . 35.4 Cg_endo -78.3 90.91 1.23 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.409 2.073 . . . . 0.0 110.271 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.525 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 95.7 m -105.52 116.89 32.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 0.0 109.622 -179.833 -66.036 -71.452 -55.896 104.091 2.019 104.105 -71.354 -42.144 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.707 ' SG ' HG22 ' B' ' 7' ' ' THR . 1.2 m -103.25 129.15 50.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.879 . . . . 0.0 109.447 179.84 -97.793 -88.605 -57.137 104.135 2.02 104.158 -69.349 -49.875 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.609 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -118.4 -19.01 9.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.634 ' HB3' ' HA ' ' B' ' 5' ' ' SER . . . -90.1 164.51 14.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.513 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.573 ' CD1' ' O ' ' A' ' 13' ' ' ALA . 23.1 m-85 -139.1 103.72 4.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.893 . . . . 0.0 109.437 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 15' ' ' ILE . 6.4 tt -60.07 124.82 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.455 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.31 -36.55 71.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.452 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 6.2 mtt180 -81.34 148.18 62.3 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.487 ' HB3' ' CG ' ' A' ' 57' ' ' TRP . 35.6 Cg_endo -78.1 170.25 19.04 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.614 2.209 . . . . 0.0 110.511 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.537 HD11 ' CZ3' ' A' ' 57' ' ' TRP . 0.0 OUTLIER -109.74 170.59 5.2 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.297 -0.877 . . . . 0.0 109.294 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 19' ' ' LEU . 35.9 Cg_endo -78.74 120.24 4.66 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.587 2.191 . . . . 0.0 110.18 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.41 ' CG ' ' CE1' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -68.63 -7.97 37.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.63 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.23 -0.13 57.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 109.8 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.469 ' HB2' ' HG2' ' A' ' 20' ' ' PRO . 14.3 m-70 -132.4 10.38 4.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.095 -1.003 . . . . 0.0 109.772 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 20' ' ' PRO . 9.6 mt -91.96 87.74 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.56 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -56.15 -65.13 0.65 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 109.544 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -157.55 152.09 25.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.487 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.931 ' OH ' HG23 ' A' ' 62' ' ' ILE . 29.1 p90 -123.25 -178.26 3.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.558 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.692 ' CZ ' HG11 ' A' ' 40' ' ' VAL . 8.6 p90 -171.13 157.44 5.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 109.325 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.727 ' CE2' HG22 ' A' ' 39' ' ' VAL . 85.9 m-85 -89.82 165.09 14.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 0.0 109.583 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.544 HG21 ' O ' ' A' ' 9' ' ' PRO . 16.9 p -147.53 143.37 27.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.864 . . . . 0.0 109.404 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.452 ' OG ' ' HB3' ' A' ' 37' ' ' PRO . 4.6 t -179.04 -159.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.915 . . . . 0.0 109.536 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.94 -80.55 1.08 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.593 ' HD2' ' CE1' ' B' ' 12' ' ' PHE . 21.2 mttt -89.79 30.29 1.07 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 109.363 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 m -128.54 156.36 43.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.487 -179.883 -42.144 -71.354 -55.896 104.105 2.019 104.091 -71.452 -66.036 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.08 -35.41 78.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.463 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.01 149.69 28.1 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.241 -0.912 . . . . 0.0 109.389 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.452 ' HB3' ' OG ' ' A' ' 31' ' ' SER . 35.6 Cg_endo -78.1 131.75 11.12 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.617 2.211 . . . . 0.0 110.231 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.438 ' HB1' ' HE1' ' A' ' 14' ' ' TYR . . . -149.71 173.67 13.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 109.553 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.727 HG22 ' CE2' ' A' ' 29' ' ' TYR . 37.3 t -95.62 166.29 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.425 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.692 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 41.0 t -140.37 112.59 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.284 -0.885 . . . . 0.0 109.309 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -93.29 112.72 24.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.556 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.668 HG21 ' HE2' ' A' ' 28' ' ' PHE . 61.3 t -100.51 126.84 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.474 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 47' ' ' ARG . 61.8 p -89.76 -169.64 2.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 0.0 109.545 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -77.8 -16.59 58.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.493 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.91 29.2 1.22 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 109.477 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.29 26.7 4.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 8.1 mmm180 -90.02 114.14 25.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.445 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.654 ' HG3' HG22 ' A' ' 42' ' ' VAL . 6.3 mp0 -90.77 126.97 36.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 0.0 109.49 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 50' ' ' CYS . 54.7 t -118.58 160.27 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 109.428 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.487 ' N ' HG12 ' A' ' 49' ' ' VAL . 30.2 m -108.52 130.82 55.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 109.553 -179.958 -49.875 -69.349 -57.137 104.158 2.02 104.135 -88.605 -97.793 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 39' ' ' VAL . . . -136.74 134.93 37.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.373 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.522 ' O ' HG11 ' A' ' 58' ' ' VAL . 10.6 t30 -89.91 145.56 33.46 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.355 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HD2' ' OD1' ' A' ' 52' ' ' ASN . 35.5 Cg_endo -78.01 5.09 5.6 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.598 2.199 . . . . 0.0 110.488 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -98.23 11.17 38.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 109.405 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.534 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 15.1 mmtt -93.52 -178.14 4.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.523 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 57' ' ' TRP . 2.9 ptpt -103.72 -23.46 13.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.474 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.619 ' CH2' HG22 ' A' ' 58' ' ' VAL . 46.7 p-90 -102.08 -22.34 14.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 0.0 109.534 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.74 ' O ' HD12 ' A' ' 62' ' ' ILE . 83.7 t -63.46 -60.39 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.152 -0.967 . . . . 0.0 108.893 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -59.1 -16.98 22.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.343 -0.848 . . . . 0.0 108.767 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 57' ' ' TRP . 5.0 mt-10 -68.36 -44.68 74.69 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.442 -0.786 . . . . 0.0 109.138 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.483 ' CE2' HD12 ' A' ' 19' ' ' LEU . 14.0 m-85 -71.36 -41.26 69.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.0 109.035 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.931 HG23 ' OH ' ' A' ' 27' ' ' TYR . 2.0 mp -62.25 -31.98 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -0.865 . . . . 0.0 109.5 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -81.62 -31.02 32.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.51 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.0 p -79.27 -18.14 53.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 109.463 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -46.24 8.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 67' ' ' MET . 3.4 mt-10 -88.9 52.41 2.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.456 ' O ' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -53.74 -171.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.234 -0.916 . . . . 0.0 109.441 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.45 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.546 ' O ' ' CG ' ' B' ' 3' ' ' TYR . 35.4 Cg_endo -77.93 -89.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.664 2.243 . . . . 0.0 110.415 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' B' ' 2' ' ' PRO . 55.5 m-85 -161.49 63.48 0.26 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.502 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 49.2 m -87.35 59.57 5.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.427 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.634 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 8.3 p -89.97 52.44 2.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.408 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . 0.4 ' C ' ' SG ' ' A' ' 50' ' ' CYS . 29.9 m-20 -138.79 164.66 29.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.472 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.707 HG22 ' SG ' ' A' ' 11' ' ' CYS . 76.5 p -72.09 159.99 33.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.895 . . . . 0.0 109.485 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 8' ' ' THR . 22.9 m -113.82 132.35 22.66 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 109.281 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' PRO . . . . . 0.542 ' O ' HG21 ' B' ' 30' ' ' THR . 35.3 Cg_endo -78.28 90.94 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.426 2.084 . . . . 0.0 110.251 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' CYS . . . . . 0.516 ' O ' ' CE1' ' B' ' 12' ' ' PHE . 95.3 m -105.6 116.91 32.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.6 -179.844 -66.081 -71.398 -55.94 104.102 2.019 104.087 -71.359 -42.13 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.716 ' SG ' HG22 ' A' ' 7' ' ' THR . 1.2 m -103.22 129.19 50.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.389 179.88 -97.853 -88.585 -57.073 104.18 2.021 104.127 -69.392 -49.833 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' B' ' 12' ' ' PHE . 0.2 OUTLIER -118.51 -18.91 8.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 109.425 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.633 ' HB3' ' HA ' ' A' ' 5' ' ' SER . . . -90.13 164.53 14.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.493 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . 0.575 ' CD1' ' O ' ' B' ' 13' ' ' ALA . 23.1 m-85 -139.15 103.73 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ILE . . . . . 0.562 ' O ' HG23 ' B' ' 15' ' ' ILE . 6.5 tt -60.05 124.79 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.902 . . . . 0.0 109.518 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.29 -36.58 71.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.92 . . . . 0.0 109.443 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -81.31 148.23 62.56 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.494 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.49 ' HB3' ' CG ' ' B' ' 57' ' ' TRP . 35.6 Cg_endo -78.15 170.25 19.0 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.607 2.204 . . . . 0.0 110.495 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.543 HD11 ' CZ3' ' B' ' 57' ' ' TRP . 0.0 OUTLIER -109.72 170.61 5.18 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 0.0 109.278 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' B' ' 19' ' ' LEU . 35.5 Cg_endo -78.76 120.23 4.65 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.552 2.168 . . . . 0.0 110.156 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.403 ' CG ' ' CE1' ' B' ' 61' ' ' TYR . 0.0 OUTLIER -68.59 -8.02 38.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 109.594 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.21 -0.18 57.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.789 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.469 ' HB2' ' HG2' ' B' ' 20' ' ' PRO . 14.3 m-70 -132.36 10.33 4.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.098 -1.001 . . . . 0.0 109.754 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.469 HG13 ' O ' ' B' ' 20' ' ' PRO . 9.6 mt -91.92 87.73 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -56.17 -65.17 0.65 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.552 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -157.5 152.14 25.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.921 ' OH ' HG23 ' B' ' 62' ' ' ILE . 29.0 p90 -123.34 -178.31 3.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 109.571 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.702 ' CZ ' HG11 ' B' ' 40' ' ' VAL . 8.6 p90 -171.1 157.5 5.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.319 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.724 ' CE2' HG22 ' B' ' 39' ' ' VAL . 85.9 m-85 -89.84 165.09 14.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.574 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.542 HG21 ' O ' ' B' ' 9' ' ' PRO . 16.9 p -147.54 143.42 27.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.382 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.434 ' OG ' ' HB3' ' B' ' 37' ' ' PRO . 4.6 t -179.09 -159.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 109.535 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.98 -80.55 1.08 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.597 ' HD2' ' CE1' ' A' ' 12' ' ' PHE . 21.3 mttt -89.85 30.31 1.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -1.129 . . . . 0.0 109.369 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 m -128.51 156.36 43.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.264 -0.897 . . . . 0.0 109.536 -179.893 -42.13 -71.359 -55.94 104.087 2.019 104.102 -71.398 -66.081 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -35.46 78.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.01 149.67 28.04 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 109.341 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.434 ' HB3' ' OG ' ' B' ' 31' ' ' SER . 35.9 Cg_endo -78.06 131.79 11.17 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.597 2.198 . . . . 0.0 110.277 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.445 ' HB1' ' HE1' ' B' ' 14' ' ' TYR . . . -149.69 173.67 13.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.937 . . . . 0.0 109.586 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.724 HG22 ' CE2' ' B' ' 29' ' ' TYR . 37.3 t -95.6 166.34 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.415 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.702 HG11 ' CZ ' ' B' ' 28' ' ' PHE . 41.1 t -140.45 112.63 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.877 . . . . 0.0 109.322 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -93.32 112.75 24.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.536 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.668 HG22 ' HG3' ' B' ' 48' ' ' GLN . 61.2 t -100.51 126.8 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.454 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.46 ' OG1' ' HB2' ' B' ' 47' ' ' ARG . 62.0 p -89.75 -169.63 2.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -0.853 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -77.8 -16.51 58.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.508 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.96 29.18 1.23 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.27 26.69 4.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.399 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ARG . . . . . 0.46 ' HB2' ' OG1' ' B' ' 43' ' ' THR . 8.1 mmm180 -90.01 114.16 25.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.473 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . 0.668 ' HG3' HG22 ' B' ' 42' ' ' VAL . 6.3 mp0 -90.75 127.01 36.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.487 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.49 HG12 ' N ' ' B' ' 50' ' ' CYS . 54.6 t -118.6 160.23 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' CYS . . . . . 0.49 ' N ' HG12 ' B' ' 49' ' ' VAL . 30.0 m -108.47 130.84 55.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 -179.939 -49.833 -69.392 -57.073 104.127 2.021 104.18 -88.585 -97.853 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' B' ' 39' ' ' VAL . . . -136.81 134.94 37.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -0.875 . . . . 0.0 109.347 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . 0.531 ' O ' HG11 ' B' ' 58' ' ' VAL . 10.6 t30 -89.89 145.53 33.44 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 109.363 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . 0.448 ' HD2' ' OD1' ' B' ' 52' ' ' ASN . 35.3 Cg_endo -78.05 5.13 5.59 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.587 2.191 . . . . 0.0 110.485 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -98.29 11.27 38.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.405 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.535 ' HB2' ' CG2' ' B' ' 58' ' ' VAL . 15.1 mmtt -93.56 -178.12 4.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.917 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' B' ' 57' ' ' TRP . 2.9 ptpt -103.75 -23.45 13.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.418 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' TRP . . . . . 0.618 ' CH2' HG22 ' B' ' 58' ' ' VAL . 46.4 p-90 -102.05 -22.42 14.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.457 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.744 ' O ' HD12 ' B' ' 62' ' ' ILE . 83.8 t -63.41 -60.35 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.136 -0.977 . . . . 0.0 108.889 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -59.15 -16.96 22.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.295 -0.878 . . . . 0.0 108.698 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' B' ' 57' ' ' TRP . 5.0 mt-10 -68.42 -44.74 74.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.415 -0.803 . . . . 0.0 109.053 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.496 ' HE2' HD12 ' B' ' 19' ' ' LEU . 14.0 m-85 -71.28 -41.25 70.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.307 -0.871 . . . . 0.0 109.063 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.921 HG23 ' OH ' ' B' ' 27' ' ' TYR . 2.0 mp -62.31 -31.98 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -81.64 -30.92 32.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.546 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 56.3 p -79.33 -18.14 53.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 109.447 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.13 -46.28 8.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 109.46 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' B' ' 67' ' ' MET . 3.4 mt-10 -88.88 52.44 2.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.18 -0.95 . . . . 0.0 109.482 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' MET . . . . . 0.46 ' O ' ' O ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -53.73 -171.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.455 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.483 179.988 . . . . . . . . 1 1 . 1 stop_ save_